Tucatinib favourably modulates the immune microenvironment and synergises with anti-PD1 therapy in a trastuzumab resistant HER2 murine model

Ran Li; Sneha Sant; Emmaline Brown; Franco Caramia; Ann Byrne; Kylie Clarke; Michael Neeson; Paul J Neeson; Phillip K Darcy; Scott Peterson; Sherene Loi

Conference Proceedings

Tucatinib favourably modulates the immune microenvironment and synergises with anti-PD1 therapy in a trastuzumab resistant HER2 murine model

Ran Li, Sneha Sant, Emmaline Brown, Franco Caramia, Ann Byrne, Kylie Clarke, Michael Neeson, Paul J Neeson, Phillip K Darcy, Scott Peterson, Sherene Loi

CANCER RESEARCH | AMER ASSOC CANCER RESEARCH | Published : 2021

DOI: 10.1158/1538-7445.sabcs20-ps10-04

University of Melbourne Researchers

Phillip Darcy Author The Sir Peter Maccallum Department of Oncology

Sneha Sant Author The Sir Peter Maccallum Department of Oncology

Sherene Loi Author The Sir Peter Maccallum Department of Oncology

Paul Neeson Author The Sir Peter Maccallum Department of Oncology

Keywords

Science & Technology

Life Sciences & Biomedicine

Oncology

Tucatinib favourably modulates the immune microenvironment and synergises with anti-PD1 therapy in a trastuzumab resistant HER2 murine model

University of Melbourne Researchers

Keywords

STUDY AT MELBOURNE

ABOUT US

CONTACT & MAPS

ALUMNI & FRIENDS

RESEARCH

ENGAGEMENT